FHTX
Price
$5.13
Change
+$0.18 (+3.64%)
Updated
Jul 3 closing price
Capitalization
277.59M
39 days until earnings call
PLRX
Price
$1.26
Change
+$0.06 (+5.00%)
Updated
Jul 3 closing price
Capitalization
73.66M
38 days until earnings call
Interact to see
Advertisement

FHTX vs PLRX

Header iconFHTX vs PLRX Comparison
Open Charts FHTX vs PLRXBanner chart's image
Foghorn Therapeutics
Price$5.13
Change+$0.18 (+3.64%)
Volume$80.45K
Capitalization277.59M
Pliant Therapeutics
Price$1.26
Change+$0.06 (+5.00%)
Volume$1.12M
Capitalization73.66M
FHTX vs PLRX Comparison Chart in %
Loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FHTX vs. PLRX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a StrongBuy and PLRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (FHTX: $5.13 vs. PLRX: $1.26)
Brand notoriety: FHTX and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 60% vs. PLRX: 94%
Market capitalization -- FHTX: $277.59M vs. PLRX: $73.66M
FHTX [@Biotechnology] is valued at $277.59M. PLRX’s [@Biotechnology] market capitalization is $73.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, FHTX is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 3 bullish TA indicator(s).

  • FHTX’s TA Score: 4 bullish, 3 bearish.
  • PLRX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than PLRX.

Price Growth

FHTX (@Biotechnology) experienced а +5.56% price change this week, while PLRX (@Biotechnology) price change was -3.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

FHTX is expected to report earnings on Aug 12, 2025.

PLRX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FHTX($278M) has a higher market cap than PLRX($73.7M). FHTX YTD gains are higher at: 8.686 vs. PLRX (-90.433). FHTX has higher annual earnings (EBITDA): -91.89M vs. PLRX (-214.08M). PLRX has more cash in the bank: 306M vs. FHTX (221M). FHTX has less debt than PLRX: FHTX (34.9M) vs PLRX (60.2M). FHTX has higher revenues than PLRX: FHTX (23.5M) vs PLRX (0).
FHTXPLRXFHTX / PLRX
Capitalization278M73.7M377%
EBITDA-91.89M-214.08M43%
Gain YTD8.686-90.433-10%
P/E RatioN/AN/A-
Revenue23.5M0-
Total Cash221M306M72%
Total Debt34.9M60.2M58%
TECHNICAL ANALYSIS
Technical Analysis
FHTXPLRX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QUBSF6.500.20
+3.17%
Qantas Airways Ltd.
MIAPF10.68N/A
N/A
MINTO APT REAL ESTATE INVT TR
KSKGF1.40N/A
N/A
Kingsgate Consolidated Ltd.
SLRK9.01N/A
N/A
Solera National Bancorp, Inc.
TPZEF18.73-0.14
-0.74%
TOPAZ ENERGY CORP.

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with ABOS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+3.64%
ABOS - FHTX
54%
Loosely correlated
+2.65%
IPSC - FHTX
49%
Loosely correlated
+0.02%
IMNM - FHTX
48%
Loosely correlated
+2.43%
NAUT - FHTX
48%
Loosely correlated
+4.73%
CRSP - FHTX
48%
Loosely correlated
+0.97%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with ITRM. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then ITRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+5.00%
ITRM - PLRX
41%
Loosely correlated
-0.42%
SRRK - PLRX
41%
Loosely correlated
+1.24%
LXRX - PLRX
41%
Loosely correlated
-1.63%
FHTX - PLRX
40%
Loosely correlated
+3.64%
OCUL - PLRX
40%
Loosely correlated
+1.69%
More